CNBC Investing Club

Cramer's Investing Club: We are nibbling on this drug stock amid the broad market sell-off

David Ricks, CEO, Eli Lilly
Scott Mlyn | CNBC

(This article was sent first to members of the CNBC Investing Club with Jim Cramer. To get the real-time updates in your inbox, subscribe here.)

Shortly before the closing bell, we will be buying 25 shares of Eli Lilly (LLY) at roughly $243.81. Following the trade, the Charitable Trust will own 400 shares of Eli Lilly. This buy will increase Eli Lilly's weight in the portfolio from about 2.28% to 2.43%.